Results 181 to 190 of about 117,898 (292)

Biological Features of KLC2 Mutations in Chronic Myeloid Leukemia and Their Contribution to Inducing Drug Resistance. [PDF]

Oncol Res
Bera R, Ochi Y, Huang YJ, Kuo MC, Yoshida K, Ogawa S, Shih LY.   +6 more
europepmc   +1 more source

Characterisation of Antifungal Prophylaxis and Therapy Among Inpatients With Haematological Malignancies in Non‐Research Clinical Setting: A Multicentre Italian Experience

Mycoses, Volume 69, Issue 1, January 2026.
ABSTRACT Background Invasive fungal infections (IFI) are a prominent cause of morbidity and mortality among patients with haematological malignancies (HMs). Diagnostic work‐up excluding IFI is mandatory in case of persistent fever while antifungal treatment (AFT) is started.
Criscuolo Marianna, Bonanni Matteo, Martino Giordana, Farina Francesca, Verga Luisa, Marchesi Francesco, Basilico Claudia, Del Principe Maria Ilaria, Tisi Maria Chiara, Cattaneo Chiara, Picardi Marco, Bonuomo Valentina, Fracchiolla Nicola, Candoni Anna, Perruccio Katia, Stanzani Marta, Cesaro Simone, Fanci Rosa, Dargenio Michela, Forghieri Fabio, Ballanti Stelvio, Cudillo Laura, Cuccaro Annarosa, Carraro Francesca, Zama Daniele, Armiento Daniele, Garzia Maria Grazia, Spolzino Angelica, Busca Alessandro, Pagano Livio   +29 more
wiley   +1 more source

Enhanced formation of tertiary lymphoid structures shapes the anti-tumor microenvironment in gastrointestinal stromal tumors after imatinib targeted therapy. [PDF]

Theranostics
Tao P, Wang J, Fan P, Liu W, Lu W, Hu Y, Lu Q, Ma L, Tong H, Zhang Y.   +9 more
europepmc   +1 more source

A PATIENT WITH GASTROINTESTINAL STROMAL TUMOR OF THE STOMACH WITH MULTIPLE HEPATIC METASTASES WHO DIED OF SEPTICEMIA FOLLOWING ABSCESS FORMATION AFTER ADMINISTRATION OF IMATINIB MESYLATE

, 2007
Mami Watanabe, Tetsuya Naito, Kohei NIHEI, Satoshi Suzuki, Takeshi Mishina, Shinya Uchigasaki, Masayuki Fukase   +6 more
openalex   +2 more sources

Immune System and Hepatic Stellate Cells’ Crosstalk in Liver Fibrosis: Pathways and Therapeutic Potential

Journal of Immunology Research, Volume 2026, Issue 1, 2026.
Liver fibrosis, characterized by the excessive deposition of extracellular matrix (ECM) driven by hepatic stellate cells (HSCs) activation, remains a critical challenge due to its progression to cirrhosis and hepatocellular carcinoma (HCC). This review clarifies the complex crosstalk between the immune system and HSCs, highlighting key cellular players
Wahyu Widowati, Adilah Hafizha Nur Sabrina, Annisa Firdaus Sutendi, Fadhilah Haifa Zahiroh, Aris Muhamad Nurjamil, Teresa Liliana Wargasetia, Ita Margaretha Nainggolan, Rizal Azis, Elham Rismani, Massoud Vosough, Poorani Gurumallesh Prabu   +10 more
wiley   +1 more source

Long-term survival and successful pregnancy in a Nigerian woman with concurrent diagnosis of non-Hodgkin lymphoma and chronic myeloid leukemia: a case report. [PDF]

J Med Case Rep
Ahmed IO, Ogunrinde VO, Asafa MA, Agim MB, Adeleke AA, Ayodele SO, Adesunkanmi OO, Ogunoye BT, Adegbenro ST, Bolarinwa RA, Salawu L, Durosinmi MA.   +11 more
europepmc   +1 more source

A Case of Pathological CR after Imatinib Mesylate Therapy in a Rectal GIST

, 2017
Yuzo Fukuda, Y. Fukunaga, Toshiya Nagasaki, Takashi Akiyoshi, Tsuyoshi Konishi, Yoshiya Fujimoto, Satoshi Nagayama, Masashi Ueno   +7 more
openalex   +2 more sources

The clinical efficacy and pathological assessment of neoadjuvant imatinib treatment in patients with primary gastrointestinal stromal tumors. [PDF]

J Gastrointest Oncol
Shou C, Yang W, Zhang X, Wang X, Zhang Q, Yu J.   +5 more
europepmc   +1 more source

The long-term efficacy of imatinib with hepatic resection or other local treatment for gastrointestinal stromal tumours liver metastases: a retrospective cohort study

Haoxiang Wen, Yihao Huang, Shaoqing Huang, Han Xiao, Wenxuan Xie, Qian Zhou, Li Tan, Yuqi Ding, Xiaofei Liu, Yu Yang, Zimin Song, Shunli Shen, Zebin Chen, Xinhua Zhang   +13 more
openalex   +1 more source

One-year consolidation with Ponatinib 15 mg in chronic myeloid leukaemia on deep molecular response with Imatinib. [PDF]

Ann Hematol
Pérez-Lamas L, Manzanares M, Hernández Boluda JC, Casado Montero LF, Gómez Casares MT, Ayala R, Xicoy B, Ferrer Marin F, Ortí G, De Paz Arias R, Osorio Prendes S, Perez Lopez R, Mora E, Ruiz Nuño C, Jimenez Velasco A, Boqué C, Sierra Pacho M, Martinez Lopez J, Carreño-Tarragona G, Coiras M, Garcia-Gutierrez V.   +20 more
europepmc   +1 more source